Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Tumori ; 80(6): 459-63, 1994 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-7900236

RESUMO

AIMS AND BACKGROUND: High doses of metoclopramide are contraindicated to prevent chemotherapy-induced emesis in pediatric patients, since the incidence of extrapyramidal reactions is increased in these patients. The aim of this small study was to evaluate the antiemetic activity and the safety of tropisetron (a new selective antagonist of 5-HT3 receptors) in children who suffered nausea and vomiting during previous chemotherapy courses, despite the administration of an anxiolytic agent (hydroxyzine hydrochloride). METHODS: The children with a malignant neoplasm were treated for emesis with tropisetron (5 mg o.a.d. or b.i.d.) during a total of 20 cycles of chemotherapy with carboplatin combined with other antitumor agents. RESULTS: In 14 cycles (70%), there was no vomiting. There were two or less episodes of vomiting in 2 cycles (10%), 3-4 episodes in 2 cycles (10%), and no inhibition of vomiting at all in 2 cycles (10%). In 8 cycles there were no episodes of nausea (40%), in 5 cycles (25%) there were episodes of moderate nausea, and in 4 (20%) there were episodes of severe nausea. One child had a mild headache during one cycle and moderate hypotension during another. CONCLUSIONS: The results suggest that tropisetron is both efficacious and safe for the treatment of pediatric patients.


Assuntos
Antieméticos/uso terapêutico , Antineoplásicos/efeitos adversos , Indóis/uso terapêutico , Náusea/prevenção & controle , Antagonistas da Serotonina/uso terapêutico , Vômito/prevenção & controle , Adolescente , Antineoplásicos/administração & dosagem , Criança , Pré-Escolar , Esquema de Medicação , Feminino , Humanos , Lactente , Masculino , Náusea/induzido quimicamente , Neoplasias/tratamento farmacológico , Resultado do Tratamento , Tropizetrona , Vômito/induzido quimicamente
2.
Recenti Prog Med ; 85(1): 22-8, 1994 Jan.
Artigo em Italiano | MEDLINE | ID: mdl-8184176

RESUMO

Giant cell arteritis (GCA) or temporal arteritis is an entity of unknown aetiology and uncertain autonomy for the close relationship with polymyalgia rheumatica (PMR). This work describes four patients with GCA alone. All patients had clinical and laboratoristic evidence of the disease and were treated with steroids. The distribution of HLA antigens showed an increased occurrence of DR4 and B8 antigens. Unfortunately, the small number of patients and the short period of observation don't allow to prove the exact nature of the link between GCA and PMR.


Assuntos
Arterite de Células Gigantes/complicações , Polimialgia Reumática/complicações , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Polimialgia Reumática/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...